Irrespective of the state of the market, penny stocks have always had a special appeal. This is usually due to the possibility of generating handsome returns within a short timespan. Moreover, these stocks are extremely cheap. In fact, by definition penny stocks are equities trading below $5 a share. While you can make money with penny stocks, it’s also true that there is a possibility of making losses. Hence, you have to do your research thoroughly.
The best ways to go about choosing a list of penny stocks is by watching the market closely. Make sure to keep track of the movements. Learning how to read penny stock technical indicators could be a place to start. Things like increased volume, big price movement, or rising RSI/MACD indicators could signal potential bullish or bearish moves. Keeping this is mind here is a look at three penny stocks which have made significant gains recently.
Biotech Penny Stocks To Watch #1
Vivos Inc. (RDGL)
The first penny stock to watch is Vivos Inc. (RDGL Stock Report). The biotech company focuses on cancers specifically in humans and animals. Some favorable penny stock news released by the company saw RDGL stock skyrocket in July. Since completing a 1 for 8 reverse stock split earlier this summer, Vivos has managed to reach highs of $0.10. If you look at a chart, you’ll notice the price of Vivos stock hit lows of $0.025 on June 28 and has considerably increased over the last few weeks.
On Monday morning (7-29), Vivos announced that the University of Missouri is finishing up the final report on the IsoPet therapy conducted last year. Vivos says that after the report is received, it plans to submit it to the FDA and start scheduling meetings to go over key points of a completed test plan.
Biotech Penny Stocks To Watch #2
Pieris Pharmaceuticals (PIRS)
The other biotech penny stock to watch recently has been Pieris Pharmaceuticals (PIRS Stock Report). Monday saw shares of this stock skyrocket to highs of $5.84. Yes, this is no longer a penny stock by definition. However, it’s important to note the rapid rise that PIRS stock has seen within just a few short months. On April 29, the stock was trading as los as $3.07. That means that within just 3 months, this biotech penny stock has jumped by as much as 90%.
All the commotion from Monday stemmed from news that the European Respiratory Society accepted Pieris Pharma’s Phase 1 Study of PRS-060 on July 26. As with many biotechnology penny stocks, positive trial information can act as a true catalyst. So it makes sense as to why PIRS stock is up so much today and this quarter in particular.
Biotech Penny Stocks To Watch #3
Acasti Pharmaceuticals (ACST)
Last but not least; Acasti Pharmaceuticals (ACST Stock Report) reached fresh 2019 highs on Monday. ACST stock hit highs of $2.66 before the lunch hour as one of the biggest moving healthcare stocks to watch.
Why are ACST shares so explosive right now? Well, as the company stated, “several recently issued independent analyst reports [were] issued by third-party investment banks.” These reports pointed out the current Phase 3 TRILOGY clinical studies for its CaPre(R).
There appears to be high expectations for top-line results for the primary endpoint of lowering triglycerides for TRILOGY 1 this December and TRILOGY 2 in January of next year. Additionally, and possibly just as important, the company said it’s not planning to raise additional capital in the near future. That could mean less dilution overall.
The Company also reaffirmed it has no current plans to raise capital and management believes Acasti is sufficiently capitalized beyond completion of the Phase 3 trials. This includes funding to continue work on the New Drug Application (NDA) for CaPre, which management plans to submit to the FDA mid-2020, assuming Phase 3 is successful, as well as on-going business and US commercial launch activities. The Company had $34.4 million of cash, cash equivalents and marketable securities as of March 31, 2019.Acasti Pharma, July 25 Press Release